Post BostonGene and the Parker Institute for Cancer Immunotherapy Collaborate to Generate Comprehensive Longitudinal Multi-Omic Data for Predicting Immunotherapy Outcomes
Post Parker Institute for Cancer Immunotherapy Named to Top 10 List of Most Innovative Companies in Biotech by Fast Company
Post The Parker Institute for Cancer Immunotherapy Appoints Seasoned Health Care Leader Frederic Pla as Chief Operating Officer
Post Parker Institute for Cancer Immunotherapy Brings the Power of Its Integrated Network to ASCO 2026